The House Appropriations Committee released a draft spending bill this month that proposes increased funding for OPA. The Committee proposes $15,238,000 in funding for OPA, which is $5 million more…
OPA recently posted a program update entitled “Best Practices for Covered Entities: Resolving Contract Pharmacy Related Non-Compliance.” In the update, OPA states that it has concerns about contract pharmacies and/or…
HRSA proposed today a 12-month delay of the effective date of the 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMP) rule, from July 1, 2018 to July 1, 2019.…
On April 30, 2018, the White House Office of Management and Budget (OMB) published a notice that HHS has withdrawn a proposed rule that would have amended the 340B Ceiling…
The 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMP) rule may be a delayed a fifth time. On March 27, 2018, HRSA sent to the White House Office of…
The 340B annual recertification period for HRSA grantees will be from February 7, 2018 to March 7, 2018. Recertification must be completed through the new 340B Office of Pharmacy Affairs…
HRSA sent a new proposed rule on 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMPs) to the White House Office of Management and Budget (OMB) for review on October…
The OPA 340B database will be unavailable from August 15, 2017 through mid-September 2017 as HRSA transitions to a new database system. During this time, covered entities will not be…
On July 13, the Centers for Medicare and Medicaid Services, or CMS, released a proposal to reduce Medicare reimbursement for separately payable 340B drugs administered in hospitals from ASP +…
As part of President Trump’s budget released today, HRSA submitted its budget justification that includes its pledge to “work with Congress to develop a legislative proposal to improve 340B Program…